CARE Ratings Gains 5.85%: 3 Key Factors Driving the Week’s Momentum

15 June: Upgrade to Buy Spurs Early Week Gains

CARE Ratings began the week on a positive note, closing at ₹1,649.80 on 15 June, up 1.62% from the previous close of ₹1,623.55. This price movement coincided with MarketsMOJO’s upgrade of the stock’s rating from Hold to Buy, reflecting strong financial results and a bullish technical outlook. The upgrade was underpinned by a robust return on capital employed of 24.81%, net-debt-free status, and consistent profit growth, with profit before tax rising 28.77% quarter-on-quarter to ₹56.30 crores.

Technical indicators supported this optimism, with the weekly MACD turning bullish and daily moving averages signalling positive momentum. The stock’s premium valuation, including a price-to-book ratio of 5.3 and a PEG ratio of 1.2, was deemed justified by its strong fundamentals and institutional investor confidence, with 54.63% holdings by sophisticated market participants.

16 June: Technical Momentum Strengthens Amid Mixed Market Signals

On 16 June, CARE Ratings closed unchanged at ₹1,638.90, down 0.66% from the prior day’s close, despite the broader Sensex advancing 0.49%. The day’s trading reflected a consolidation phase following the upgrade, with the stock fluctuating between ₹1,610.10 and ₹1,674.15. Technical momentum remained positive, with daily moving averages firmly bullish and weekly MACD sustaining its bullish stance.

However, monthly momentum indicators such as the MACD and Know Sure Thing (KST) remained mildly bearish, signalling caution for longer-term investors. The Relative Strength Index (RSI) was neutral, suggesting no immediate overbought or oversold conditions. Bollinger Bands on weekly and monthly charts continued to indicate an upward trend, while volume trends remained inconclusive, with On-Balance Volume (OBV) showing no clear direction.

17 June: Momentum Moderates to Mildly Bullish

The stock experienced a slight pullback on 17 June, closing at ₹1,638.90, down 0.66% from the previous day. This dip reflected a cautious market response amid mixed technical signals. While the weekly MACD remained bullish, the monthly MACD and KST indicators turned mildly bearish, suggesting a moderation in momentum. The RSI remained neutral, and Bollinger Bands continued to support a bullish channel.

Volume indicators showed some weakness, with weekly OBV turning mildly bearish and monthly OBV flat, indicating limited conviction behind the price moves. Despite this, the stock remained well above its 52-week low of ₹1,393.95, providing a technical cushion. The recent Mojo Grade upgrade to Buy and a Mojo Score of 71.0 continued to reflect positive analyst sentiment, though investors were advised to monitor key support levels closely.

19 June: Strong Finish on Heavy Volume

CARE Ratings closed the week with a strong rally on 19 June, surging 4.31% to ₹1,718.55 on significantly higher volume of 9,652 shares, compared to daily volumes below 1,100 earlier in the week. This sharp gain came despite the Sensex declining 0.30%, underscoring the stock’s relative strength and renewed buying interest.

The price breakout above the week’s previous highs and the surge in volume suggest a potential resumption of the bullish trend. This move capped a week of overall outperformance, with the stock gaining 5.85% compared to the Sensex’s 2.35%. The strong finish may reflect growing investor confidence following the fundamental upgrade and improving technical momentum.

Daily Price Performance vs Sensex

Key Takeaways

Positive Signals: The MarketsMOJO upgrade to Buy on 15 June was a pivotal event, reflecting strong financials and bullish technical indicators. CARE Ratings demonstrated resilience with a 5.85% weekly gain, outperforming the Sensex by 3.50%. The stock’s net-debt-free status, high return on capital employed, and strong institutional ownership underpin its fundamental strength. Technical momentum, particularly daily moving averages and weekly MACD, supports a positive near-term outlook. The surge in volume and price on 19 June further confirms renewed buying interest.

Cautionary Notes: Despite short-term strength, monthly momentum indicators such as MACD and KST remain mildly bearish, signalling that longer-term trend confirmation is pending. Volume trends have been mixed, with On-Balance Volume showing limited conviction. The stock trades at a premium valuation, which may limit upside if growth moderates. Investors should monitor key support levels near ₹1,610 and watch for sustained volume confirmation to validate the bullish momentum.

Conclusion

CARE Ratings Ltd’s performance during the week of 15 to 19 June 2026 was characterised by a strong fundamental upgrade and a shift towards bullish technical momentum. The stock’s 5.85% gain outpaced the Sensex’s 2.35% rise, driven by improved financial metrics, a positive technical outlook, and increased investor interest. While short-term indicators are encouraging, mixed monthly signals and valuation premiums counsel a balanced approach. The stock remains well positioned within the capital markets sector, with its recent upgrade and volume-backed price gains suggesting potential for further appreciation, provided key technical supports hold and broader market conditions remain favourable.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today